Vanfund Urban Investment and Development Co., Ltd. (SHE:000638)
0.8900
-0.0500 (-5.32%)
Apr 15, 2026, 9:30 AM CST
SHE:000638 Revenue
Vanfund Urban Investment and Development had revenue of 5.96M CNY in the quarter ending March 31, 2026, a decrease of -94.10%. This brings the company's revenue in the last twelve months to 151.49M, down -67.41% year-over-year. In the year 2025, Vanfund Urban Investment and Development had annual revenue of 246.58M, down -37.01%.
Revenue (ttm)
151.49M
Revenue Growth
-67.41%
P/S Ratio
1.83
Revenue / Employee
964.91K
Employees
157
Market Cap
277.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 246.58M | -144.89M | -37.01% |
| Dec 31, 2024 | 391.47M | 223.96M | 133.70% |
| Dec 31, 2023 | 167.51M | 9.80M | 6.22% |
| Jan 1, 2023 | 157.71M | -164.73M | -51.09% |
| Jan 1, 2022 | 322.43M | 211.44M | 190.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi AppTec | 46.20B |
| Shenzhen Mindray Bio-Medical Electronics | 33.40B |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 32.56B |
| Shanghai United Imaging Healthcare | 14.23B |
| Sailong Pharmaceutical Group | 618.17M |
| Guangzhou Jet Bio-Filtration | 548.01M |
| Tiansheng Pharmaceutical Group | 514.09M |
| Suzhou Iron Technology CO.,LTD | 427.22M |